We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$49B
AUM Growth
+$3.53B
(+7.8%)
Cap. Flow
+$4.13B
Cap. Flow
% of AUM
8.42%
Top 10 Holdings %
Top 10 Hldgs %
10.78%
Holding
2,899
New
681
Increased
729
Reduced
681
Closed
701
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$365M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$297M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$290M |
| 5 |
Applied Materials
AMAT
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$290M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Johnson Controls International
JCI
|
+$275M |
| 4 |
L3Harris
LHX
|
+$235M |
| 5 |
Visa
V
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.53% |
| 2 | Industrials | 11.09% |
| 3 | Healthcare | 8.52% |
| 4 | Consumer Discretionary | 7.23% |
| 5 | Financials | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
CALL
Thermo Fisher Scientific
TMO
$220B
| $658K | ﹤0.01% |
+1,300
| New | +$693K |
|
1652
Coherus Oncology
CHRS
$176M
| $656K | ﹤0.01% |
+175,501
| New | +$811K |
|
1653
Ethan Allen Interiors
ETD
$583M
| $651K | ﹤0.01% |
+21,772
| New | +$674K |
|
|
CERE
1654
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $650K | ﹤0.01% |
29,796
-80,953
| -73% | -$2.03M |
|
1655
Insulet
PODD
$10.2B
| $646K | ﹤0.01% |
+4,051
| New | +$907K |
|
1656
Hawkins
HWKN
$2.67B
| $643K | ﹤0.01% |
+10,927
| New | +$592K |
|
1657
AdvanSix
ASIX
$446M
| $640K | ﹤0.01% |
+20,583
| New | +$715K |
|
1658
CALL
Abbott
ABT
$193B
| $639K | ﹤0.01% |
+6,600
| New | +$693K |
|
1659
Gaotu Techedu
GOTU
$401M
| $636K | ﹤0.01% |
+230,483
| New | +$720K |
|
1660
3D Systems Corp
DDD
$601M
| $636K | ﹤0.01% |
129,456
+98,636
| +320% | +$707K |
|
1661
First Financial Bankshares
FFIN
$5.04B
| $635K | ﹤0.01% |
25,285
-4,204
| -14% | -$122K |
|
1662
MGE Energy Inc
MGEE
$3.06B
| $635K | ﹤0.01% |
9,270
-1,069
| -10% | -$81.1K |
|
1663
ePlus
PLUS
$2.31B
| $633K | ﹤0.01% |
9,967
-6,171
| -38% | -$381K |
|
1664
LifeMD
LFMD
$167M
| $630K | ﹤0.01% |
100,843
| – | – |
|
1665
Apogee Enterprises
APOG
$888M
| $630K | ﹤0.01% |
13,377
-20,151
| -60% | -$979K |
|
1666
Hercules Capital
HTGC
$3.17B
| $629K | ﹤0.01% |
38,288
-95,697
| -71% | -$1.57M |
|
1667
CALL
Ford
F
$55.4B
| $627K | ﹤0.01% |
50,500
| – | – |
|
1668
CALL
PepsiCo
PEP
$192B
| $627K | ﹤0.01% |
+3,700
| New | +$672K |
|
1669
Mitsubishi UFJ Financial
MUFG
$260B
| $624K | ﹤0.01% |
73,511
-70,102
| -49% | -$559K |
|
1670
First Financial Bancorp
FFBC
$3.6B
| $622K | ﹤0.01% |
31,757
-1,536
| -5% | -$32.9K |
|
1671
Ecovyst
ECVT
$1.1B
| $617K | ﹤0.01% |
+62,713
| New | +$670K |
|
|
SPTN
1672
DELISTED
SpartanNash
SPTN
| $615K | ﹤0.01% |
27,974
-135,060
| -83% | -$2.98M |
|
|
STLN
1673
Starling Oncology, Inc. Common Stock
STLN
$638M
| $613K | ﹤0.01% |
+437,579
| New | +$453K |
|
1674
Molson Coors Class B
TAP
$7.85B
| $612K | ﹤0.01% |
9,618
-942,092
| -99% | -$61.3M |
|
1675
Caterpillar
CAT
$393B
| $606K | ﹤0.01% |
+2,221
| New | +$603K |
|
Similar funds
BC
Balyasny Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Balyasny Asset Management held 2,899 positions worth $49B, up 7.8% from $45.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management deployed $4.13B of net new capital in Q3 2023, opening 681 new positions and adding to 729 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was McDonald's, an estimated $290M trimmed.
- Balyasny Asset Management's largest Q3 2023 buy was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
- Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $365M increase.
- Balyasny Asset Management's biggest Q3 2023 reduction was McDonald's, cutting an estimated $290M.
- Balyasny Asset Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $165M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $49B portfolio in Q3 2023.
- Balyasny Asset Management opened 681 new positions and closed 701 in Q3 2023.
- Balyasny Asset Management's portfolio value rose 7.8% quarter-over-quarter to $49B.
Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.